Alberta Investment Management Corp (AIMCo)’s Acadia Pharmaceuticals ACAD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-163,750	Closed	-$5.84M	–	494
2015 Q4	$5.84M	Buy	+163,750	New	+$5.77M	0.07%	315
2014 Q3	–	Sell	-516,896	Closed	-$11.7M	–	480
2014 Q2	$11.7M	Hold	516,896	–	–	0.13%	243
2014 Q1	$12.6M	Sell	516,896 -75,110	-13%	-$1.9M	0.15%	210
2013 Q4	$14.8M	Buy	592,006 +146,400	+33%	+$3.45M	0.19%	167
2013 Q3	$12.2M	Buy	+445,606	New	+$9.32M	0.16%	211

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ACAD Position: Q1 2016 in Review

Alberta Investment Management Corp (AIMCo) sold out of Acadia Pharmaceuticals (ACAD) in Q1 2016, closing a stake of 163,750 shares — an estimated $5.84M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ACAD in Q3 2013 and held it in 5 quarters. The position peaked at $14.8M in Q4 2013. 213 funds tracked by Wall St. Rank hold ACAD as of Q1 2016.

Alberta Investment Management Corp (AIMCo) reported no remaining Acadia Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 163,750 Acadia Pharmaceuticals shares in Q1 2016, an estimated $5.84M.
Alberta Investment Management Corp (AIMCo) first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 5 quarters.
Alberta Investment Management Corp (AIMCo)'s Acadia Pharmaceuticals position peaked at $14.8M in Q4 2013.
213 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2016.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2016, filed 12 May 2016.